NeuroPace Inc (NPCE) stock

NPCENasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/3013% above fair value

$7.56−4.46 (-37.10%)

Close on Nov 13, 2026Market cap $259.49MP/E –Yield 0.00%

NeuroPace total assets

Total assets on the balance sheet at the end of each period.

NeuroPace's total assets was $94.78M at Sep 30, 2026. For fiscal 2025 it was $105.57M, up 11.5% from the year before. The highest annual figure on record is $133.56M in fiscal 2021.

Annual total assets

Period	Period end	Value	Change
FY2025	Dec 31, 2025	$105.57M	+11.5%
FY2024	Dec 31, 2024	$94.65M	-12.1%
FY2023	Dec 31, 2023	$107.65M	-5.7%
FY2022	Dec 31, 2022	$114.11M	-14.6%
FY2021	Dec 31, 2021	$133.56M	+138.7%
FY2020	Dec 31, 2020	$55.95M	–

Quarterly total assets

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q3 FY2026	Sep 30, 2026	$94.78M	-11.6%
Q2 FY2026	Jun 30, 2026	$96.99M	-8.6%
Q1 FY2026	Mar 31, 2026	$98.90M	-10.3%
Q4 FY2025	Dec 31, 2025	$105.57M	+11.5%
Q3 FY2025	Sep 30, 2025	$107.26M	+11.4%
Q2 FY2025	Jun 30, 2025	$106.11M	+12.4%
Q1 FY2025	Mar 31, 2025	$110.21M	+11.5%
Q4 FY2024	Dec 31, 2024	$94.65M	-12.1%
Q3 FY2024	Sep 30, 2024	$96.30M	-3.0%
Q2 FY2024	Jun 30, 2024	$94.39M	-7.7%
Q1 FY2024	Mar 31, 2024	$98.85M	-7.0%
Q4 FY2023	Dec 31, 2023	$107.65M	-5.7%
Q3 FY2023	Sep 30, 2023	$99.30M	-17.6%
Q2 FY2023	Jun 30, 2023	$102.23M	-13.8%
Q1 FY2023	Mar 31, 2023	$106.27M	-17.6%
Q4 FY2022	Dec 31, 2022	$114.11M	-14.6%
Q3 FY2022	Sep 30, 2022	$120.47M	-14.7%
Q2 FY2022	Jun 30, 2022	$118.54M	-19.3%
Q1 FY2022	Mar 31, 2022	$128.98M	+156.3%
Q4 FY2021	Dec 31, 2021	$133.56M	+138.7%
Q3 FY2021	Sep 30, 2021	$141.26M	–
Q2 FY2021	Jun 30, 2021	$146.97M	–
Q1 FY2021	Mar 31, 2021	$50.32M	–
Q4 FY2020	Dec 31, 2020	$55.95M	–